Loading…

Clinical characteristics of pyogenic vertebral osteomyelitis, and factors associated with inadequate treatment response

•Staphylococcus aureus remains predominant in pyogenic vertebral osteomyelitis (PVO).•Relapse and mortality rates remain high following PVO.•Inadequate treatment response (ITR) is frequent in PVO, and prolongs treatment.•ITR was associated with severe sepsis, previous back surgery, and Escherichia c...

Full description

Saved in:
Bibliographic Details
Published in:International journal of infectious diseases 2021-07, Vol.108, p.487-493
Main Authors: Geisler Crone, Cornelia, Mose Tetens, Malte, Bengaard Andersen, Aase, Obel, Niels, Lebech, Anne-Mette
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Staphylococcus aureus remains predominant in pyogenic vertebral osteomyelitis (PVO).•Relapse and mortality rates remain high following PVO.•Inadequate treatment response (ITR) is frequent in PVO, and prolongs treatment.•ITR was associated with severe sepsis, previous back surgery, and Escherichia coli. Pyogenic vertebral osteomyelitis (PVO) is associated with a high burden of disease. Our study aimed to describe characteristics at presentation of PVO, the risk of inadequate treatment response (ITR), relapse, and death, and to determine risk factors for ITR. Patients with an ICD-10 discharge code for PVO and admission to a major Danish university hospital between November 2016 and April 2019 were included. ITR was defined as clinical, microbiological, and/or radiological progression during treatment. Data were collected through review of medical records, and logistic regression was used to determine adjusted odds ratios (aOR). Of 106 patients included, 87% presented with pain in the spine, 97% elevated CRP, 14% severe sepsis, and 13% with a history of previous spinal surgery. 39% were infected with Staphylococcus aureus and 9% with Escherichia coli. 31% responded inadequately to treatment, and risk factors for ITR were previous spinal surgery (aOR 19.29; 95% confidence interval (CI) 2.20–169.08), severe sepsis (aOR 4.59; 95% CI 1.28–15.41), and infection with Escherichia coli (aOR 8.10; 95% CI 1.71–38.45). 13% experienced relapse within the first 2 years, while the 1-year crude mortality was 12%. Staphylococcus aureus is still the main pathogen in PVO patients, and the risks of relapse and mortality remain high. Factors found to be associated with ITR were previous spinal surgery, severe sepsis, and infection with Escherichia coli.
ISSN:1201-9712
1878-3511
DOI:10.1016/j.ijid.2021.05.078